Elevance Health Inc.
ELV
414.27
USD-7.41
(-1.76%)Day's range
414.08
426.62
52 wk Range
362.21
567.26
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 121,867,000,000 | 138,639,000,000 | 156,595,000,000 | 171,340,000,000 | 176,810,000,000 | |
| Gross Profit | 33,822,000,000 | 35,994,000,000 | 39,953,000,000 | 47,010,000,000 | 157,060,000,000 | |
| Operating Income | 7,711,000,000 | 8,946,000,000 | 8,451,000,000 | 8,745,000,000 | 7,904,000,000 | |
| Net Income | 4,572,000,000 | 6,104,000,000 | 5,894,000,000 | 5,987,000,000 | 5,980,000,000 | |
| Total Assets | 86,615,000,000 | 97,460,000,000 | 102,755,000,000 | 108,928,000,000 | 116,889,000,000 | |
| Total Current Liabilities | 18,811,000,000 | 21,515,000,000 | 24,080,000,000 | 26,297,000,000 | 26,195,000,000 | |
| Total Equity | 33,199,000,000 | 36,128,000,000 | 36,330,000,000 | 39,405,000,000 | 41,426,000,000 | |
| Free Cash Flow | 9,667,000,000 | 7,277,000,000 | 7,247,000,000 | 6,765,000,000 | 4,552,000,000 | |
| Cash from Operations | 10,688,000,000 | 8,364,000,000 | 8,399,000,000 | 8,061,000,000 | 5,808,000,000 | |
| Cash from Investing | -7,324,000,000 | -9,638,000,000 | -4,560,000,000 | -5,572,000,000 | -5,167,000,000 | |
| Cash from Financing | -2,567,000,000 | 423,000,000 | -1,318,000,000 | -3,349,000,000 | 1,193,000,000 | |
| Net Change in Cash | 804,000,000 | -861,000,000 | 2,507,000,000 | -861,000,000 | 1,762,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy